source
- Lakefront Biotherapeutics rebrands from Galapagos as it seeks turnaround from Chicago officeLakefront Biotherapeutics, formerly known as Galapagos, announced a rebranding effort aimed at reviving the company’s fortunes. The change reflects a strategic shift as the firm looks to reposition…
- Isomorphic Labs secures $2.1 billion Series B, cementing AI drug-discovery leadershipIsomorphic Labs announced on Tuesday that it has closed a $2.1 billion Series B financing round. The sizable round underscores the company’s position as a bellwether for using artificial intellige…